Carmell Co. (NASDAQ:CTCX – Get Free Report) was the target of a large decline in short interest during the month of August. As of August 31st, there was short interest totalling 55,400 shares, a decline of 5.5% from the August 15th total of 58,600 shares. Approximately 0.4% of the shares of the stock are sold short. Based on an average trading volume of 27,300 shares, the short-interest ratio is presently 2.0 days.
Institutional Investors Weigh In On Carmell
A hedge fund recently bought a new stake in Carmell stock. Warberg Asset Management LLC acquired a new position in shares of Carmell Co. (NASDAQ:CTCX – Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 45,000 shares of the company’s stock, valued at approximately $60,000. Warberg Asset Management LLC owned about 0.22% of Carmell as of its most recent SEC filing. 24.22% of the stock is owned by hedge funds and other institutional investors.
Carmell Stock Performance
Shares of CTCX stock opened at $0.43 on Wednesday. Carmell has a twelve month low of $0.43 and a twelve month high of $4.99. The stock’s fifty day simple moving average is $0.94 and its 200 day simple moving average is $1.81.
About Carmell
Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.
Featured Stories
- Five stocks we like better than Carmell
- Why Invest in High-Yield Dividend Stocks?
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- P/E Ratio Calculation: How to Assess Stocks
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Receive News & Ratings for Carmell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carmell and related companies with MarketBeat.com's FREE daily email newsletter.
